Tenax Therapeutics TENX Cash Flow Statement (2010-2026)

NASDAQ TENX
$2.14 +0.16 (+8.08%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Tenax Therapeutics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Tenax Therapeutics reported cash from operations of -$14.19M and free cash flow of -$14.19M for the quarter ended Jun 2026, down 127.8% year over year. This cash flow statement covers 65 quarters of results from Jul 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
3.80M-62.24M2.72M2.86M2.92M2.55M-1.55M1.37M1.96M-12.28M-3.80M-3.58M-3.96M-6.27M-10.41M-10.84M-15.79M-15.53M-15.71M-17.80M
Share-based Compensation
679.00646.000.12M0.01M0.01M0.97M4.14M6.06M18.40M4.79M26.50M23.90M
Asset Writedowns and Impairment
Non-cash Items
-1.72M-5.17M
Change in Interest Receivables
0.00M-0.00M-0.00M-0.00M
Cash from Operations
-3.02M-2.77M-2.94M-3.43M-3.33M-1.69M-1.72M-0.92M-2.08M-1.18M-5.20M-3.00M-3.10M-3.51M-7.00M-6.23M-9.17M-13.40M-9.31M-14.19M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF)Depreciation & Amortization
0.00M0.00M0.00M0.00M0.00M0.00M895.000.00M969.000.01M
Change in Working Capital
Change in Receivables
-1.38M0.96M-0.23M-0.20M0.78M-0.04M0.02M-0.68M0.24M0.36M-1.22M
Change in Inventory
Change in Account Payables
-1.00M-0.22M0.71M1.57M-1.32M-1.28M5.05M0.43M0.30M0.45M
Change in Accured Expenses
0.28M0.10M0.18M-0.39M-0.66M0.53M-0.63M-0.08M-0.06M1.00M-0.48M0.06M0.39M0.56M-0.61M1.04M-0.97M0.12M1.02M-0.86M
Other Working Capital Changes
-0.12M-0.19M-0.48M0.43M-0.03M-0.03M0.23M0.24M0.36M-1.22M-0.22M3.05M3.22M-2.24M-0.74M
Investing Activities
Capital Expenditures
0.00M0.00M0.01M-0.00M0.00M0.00M
Sales of Property, Plant and Equipment
0.00M0.00M157.00
Cash from Investing Activities
0.51M-0.00M-0.01M0.00M0.00M0.00M157.00
Financing Activities
Other financing activities
8.65M7.93M-7.93M13.90M0.07M-13.45M-0.51M0.00M-0.00M1.83M-1.76M0.35M0.28M3.06M11.61M30.47M13.37M
Debt Issuance and Repayment
Long-Term Debt Issuances
0.36M-0.36M0.11M0.17M0.17M0.17M0.09M0.13M0.28M
Short-Term Debt repayments
Change in Capital Stock
Net Shares Issued and Repurchased
33.003.13M3.49M1.26M
Net Equity Issued and Repurchased
9.19M
Misc.
Cash from Financing Activities
9.19M0.23M7.79M-0.09M0.00M14.01M-0.10M-0.17M-0.17M7.92M-0.13M92.01M0.07M23.56M0.28M3.06M11.61M30.50M13.37M
Change in Cash
6.68M-2.77M-2.72M4.36M-3.42M-1.68M12.29M-1.02M-2.25M-1.35M2.76M-3.17M88.93M-3.46M16.60M-5.99M-6.09M-1.80M21.19M-0.78M
Free Cash Flow
-3.02M-2.77M-2.94M-3.43M-3.33M-1.68M-1.73M-0.92M-2.08M-1.18M-5.20M-3.00M-3.10M-3.51M-7.00M-6.23M-9.17M-13.40M-9.31M-14.19M
Net Cash Flow
6.68M-2.77M-2.72M4.36M-3.42M-1.68M12.29M-1.02M-2.25M-1.35M2.72M-3.13M88.91M-3.44M16.56M-5.95M-6.11M-1.79M21.19M-0.82M